4//SEC Filing
OrbiMed Capital GP VII LLC 4
Accession 0000899243-20-008477
CIK 0001672619other
Filed
Mar 15, 8:00 PM ET
Accepted
Mar 16, 5:06 PM ET
Size
12.6 KB
Accession
0000899243-20-008477
Insider Transaction Report
Form 4
IMARA Inc.IMRA
ORBIMED ADVISORS LLC
Director10% Owner
Transactions
- Purchase
Common Stock
2020-03-12$16.00/sh+937,500$15,000,000→ 937,500 total(indirect: By OrbiMed Private Investments VII, LP) - Conversion
Common Stock
2020-03-16+1,594,902→ 2,532,402 total(indirect: By OrbiMed Private Investments VII, LP) - Conversion
Series B Preferred Stock
2020-03-16−10,046,294→ 0 total(indirect: By OrbiMed Private Investments VII, LP)→ Common Stock (1,594,902 underlying)
OrbiMed Capital GP VII LLC
Director10% Owner
Transactions
- Purchase
Common Stock
2020-03-12$16.00/sh+937,500$15,000,000→ 937,500 total(indirect: By OrbiMed Private Investments VII, LP) - Conversion
Common Stock
2020-03-16+1,594,902→ 2,532,402 total(indirect: By OrbiMed Private Investments VII, LP) - Conversion
Series B Preferred Stock
2020-03-16−10,046,294→ 0 total(indirect: By OrbiMed Private Investments VII, LP)→ Common Stock (1,594,902 underlying)
Footnotes (3)
- [F1]On March 16, 2020, the Issuer's Series B Preferred Stock converted into Common Stock on a 6.299-for-1 basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series B Preferred Stock was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date.
- [F2]These securities are held of record by OrbiMed Private Investments VII, LP, or OPI VII. OrbiMed Capital GP VII LLC, or GP VII, is general partner of OPI VII, and OrbiMed Advisors LLC, or Advisors, is the managing member of GP VII. By virtue of such relationships, GP VII and Advisors may be deemed to have voting and investment power with respect to the shares held by OPI VII. Both GP VII and Advisors may be deemed to directly or indirectly, including by reason of their mutual affiliation, to be the beneficial owners of the shares held by OPI VII. Advisors exercises investment and voting power through a management committee comprised of Carl L. Gordon, Jonathan T. Silverstein, and Sven H. Borho, each of whom disclaims beneficial ownership of the shares of OPI VII.
- [F3]Each of GP VII, Advisors and OPI VII disclaims beneficial ownership of the securities reported herein for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its pecuniary interest therein, if any. The Reporting Persons have designated a representative, David P. Bonita ("Bonita"), a member of Advisors, to serve on the Issuer's board of directors. This report shall not be deemed an admission that any such entity or person is a beneficial owner of such securities for purpose of Section 16 of the Exchange Act, or for any other purpose.
Documents
Issuer
IMARA Inc.
CIK 0001672619
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001760648
Filing Metadata
- Form type
- 4
- Filed
- Mar 15, 8:00 PM ET
- Accepted
- Mar 16, 5:06 PM ET
- Size
- 12.6 KB